You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SAR 1118

Showing 1 - 25 of 154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Discomfort in Glaucoma Patients Using Multiple Topical

Recruiting
  • Glaucoma
  • Ocular Surface Disease
  • Xiidra (Lifitegrast ophthalmic solution) 5%
  • Fountain Valley, California
    Doheny Eye Center UCLA
Oct 31, 2022

Allergic Conjunctivitis Trial in Andover (Lifitegrast, Placebo)

Completed
Has Results
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Ora
Jun 2, 2021

Dry Eye Trial in United States (Lifitegrast, Placebo)

Completed
Has Results
  • Dry Eye
  • Waterbury, Connecticut
  • +4 more
Aug 5, 2021

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • Waterbury, Connecticut
  • +12 more
Jun 2, 2021

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
Has Results
  • Dry Eye Disease
  • Artesia, California
  • +30 more
Jun 2, 2021

Hepatocellular Carcinoma, Advanced Cancer Trial in Charleston, Tainan, Taipei (Sorafenib, CVM-1118)

Terminated
  • Hepatocellular Carcinoma
  • Advanced Cancer
  • Charleston, South Carolina
  • +2 more
Jan 6, 2023

Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

Completed
  • Advanced Cancer
  • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
  • Taichung, Taiwan
  • +1 more
Nov 25, 2022

Adenocarcinoma of the Stomach Trial in Goyang (Anti-EGFR antibody in combination with weekly paclitaxel)

Recruiting
  • Adenocarcinoma of the Stomach
  • Anti-EGFR antibody in combination with weekly paclitaxel
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center
Nov 29, 2022

Prostate Cancer, Prostatic Tumors Trial (64Cu-SAR-bisPSMA)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • (no location specified)
Sep 21, 2023

Biochemical Recurrence of Malignant Tumor of Prostate Trial (64Cu-SAR-BBN)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Duarte, California
  • +7 more
Jan 15, 2023

Engagement, Patient, Quality of Life, Mood Trial in Athens, Atlanta (Behavioral Interventions, Robot Interventions)

Recruiting
  • Engagement, Patient
  • +7 more
  • Behavioral Interventions
  • Robot Interventions
  • Athens, Georgia
  • +1 more
Oct 25, 2022

Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal

Recruiting
  • Choroidal Melanoma
  • +3 more
  • Belzupacap Sarotalocan
  • +5 more
  • Birmingham, Alabama
  • +32 more
Aug 23, 2023

Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumor, Gastro-enteropancreatic Neuroendocrine Tumor Trial in Taiwan (CVM-1118)

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Kaohsiung, Taiwan
  • +6 more
Aug 24, 2021

Biochemical Recurrence of Malignant Tumor of Prostate Trial in United States (64Cu-SAR-bisPSMA)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Los Angeles, California
  • +5 more
Jun 21, 2022

Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A: Azelastine HCl 0.15% nasal spray (Azelair), Treatment B: Placebo

Recruiting
  • Seasonal Allergic Rhinitis
  • Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
  • +2 more
  • Mississauga, Ontario, Canada
    Cliantha Research
Nov 6, 2023

Heart Failure Trial in Tokyo (Ventricular Assist Device System)

Active, not recruiting
  • Heart Failure
  • Ventricular Assist Device System
  • Tokyo, Japan
    University of Tokyo
Mar 24, 2022

Mometasone Furoate Nasal Spray in Italian Children

Completed
  • Rhinitis, Allergic
  • +6 more
  • Nasal cytology
  • +3 more
  • Naples, Italy
    Second University
Mar 19, 2022

Rheumatic Diseases Trial in Ciudad Autónoma de Buenos Aires, Buenos Aires (COVID-19 Vaccine)

Recruiting
  • Rheumatic Diseases
  • COVID-19 Vaccine
  • Ciudad Autónoma de Buenos Aires, Caba, Argentina
  • +1 more
Jan 30, 2023

Engagement, Patient, Mood, Quality of Life Trial in Athens, Atlanta (SimpleC Wellness Platform with Social Robot Interaction)

Completed
  • Engagement, Patient
  • +6 more
  • SimpleC Wellness Platform with Social Robot Interaction
  • Athens, Georgia
  • +1 more
May 3, 2022

Seasonal Allergic Rhinitis Trial (Azelastine + Mometazone, nasal spray, Momat Rhino Advance)

Not yet recruiting
  • Seasonal Allergic Rhinitis
  • Azelastine + Mometazone, nasal spray
  • Momat Rhino Advance
  • (no location specified)
Dec 16, 2022

Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • (no location specified)
Dec 1, 2022

Seasonal Allergic Rhinitis Trial (Montelukast, Placebo)

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • (no location specified)
Feb 7, 2022

Aging, Sarcopenia, Nutrition, Healthy Trial in Burgos (CRE + HMB, CRE + GAA, Placebo)

Not yet recruiting
  • Aging
  • +2 more
  • CRE + HMB
  • +2 more
  • Burgos, Spain
    Juan Mielgo Ayuso
Jul 10, 2023

Prostatic Tumors, Castration-Resistant Trial in United States (64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Phoenix, Arizona
  • +6 more
May 23, 2022